[unable to retrieve full-text content]

COVID-19 patients face a much higher risk of developing blood clots than those vaccinated with AstraZeneca Plc or Pfizer Inc.'s shots, according to a large U.K. study. For every 10 million people who receive the first dose of AstraZeneca, about 66 more will suffer from a...